Boehringer Ingelheim GmbH Release: Head-To-Head Study Shows COPD Patients Achieve Significantly Better Lung Function Improvements With The Combination Of Spiriva(R) And Formoterol Than The Combination Of Salmeterol And Fluticasone Propionate
10/19/2005 5:12:17 PM
More...
|
Boehringer Ingelheim Austria GmbH Release: Asthma And COPD Patients Find New Soft Mist Inhaler Highly Effective And Easy To Use
10/19/2005 5:12:17 PM
More...
|
Corautus Genetics Inc. (CAQ) Enters Into Long Term Manufacturing Agreement With Boehringer Ingelheim Austria GmbH For Production Of VEGF-2 Plasmid DNA
10/19/2005 5:10:07 PM
More...
|
Boehringer Ingelheim Corporation Publishes Clinical Trials Online
10/19/2005 5:09:24 PM
More...
|